Lawrence P. Wennogle;Sharon Mates;Allen A. Fienberg
发明人:
Allen A. Fienberg,Sharon Mates,Lawrence P. Wennogle
申请号：
US12517945
公开号：
US09006258B2
申请日:
2007.12.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to a new use for compounds that inhibit phosphodiesterase 1 (PDE1), e.g., that inhibit PDE1-mediated suppression of the dopamine D1 receptor and/or progesterone signaling pathways, including, e.g., methods of treatment or prophylaxis for conditions which may be ameliorated by enhancing the progesterone signaling response, particularly female sexual dysfunction.
